Intellia Therapeutics, Inc.
NTLA
DELAYED 1 MONTH

15 insider filings · Latest: Jul 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 22, 2026Jul 24 9:26 PMEdward J Dulac IIIEVP, Chief Financial Officer
Sale
8,111$11.25$91.2K148,175(D)

View →

Mar 2, 2026Mar 3 9:18 PMJames BastaEVP, General Counsel
Sale
1,211$13.78$16.7K156,794(D)

View →

Mar 2, 2026Mar 3 9:16 PMEliana ClarkEVP, Chief Technical Officer
Sale
607$13.78$8.4K93,864(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 9, 2026Jun 10 11:08 PMFrank VerwielDirector
Grant/Award
13,300$12.8913,300(D)

View →

Jun 9, 2026Jun 10 11:07 PMGeorgia KerestyDirector
Grant/Award
13,300$12.8913,300(D)

View →

Jun 9, 2026Jun 10 11:06 PMJesse GoodmanDirector
Grant/Award
13,300$12.8913,300(D)

View →

Jun 9, 2026Jun 10 11:02 PMBrian GoffDirector
Grant/Award
13,300$12.8913,300(D)

View →

Jun 9, 2026Jun 10 11:01 PMFred E CohenDirector
Grant/Award
13,300$12.8913,300(D)

View →

Jun 9, 2026Jun 10 11:00 PMWilliam J ChaseDirector
Grant/Award
13,300$12.8913,300(D)

View →

Jun 9, 2026Jun 10 10:57 PMMuna BhanjiDirector
Grant/Award
13,300$12.8913,300(D)

View →

Mar 1, 2026Mar 3 9:19 PMJohn M LeonardDirector, President and CEO
Grant/Award
225,400$13.78225,400(D)

View →

Mar 1, 2026Mar 3 9:18 PMJames BastaEVP, General Counsel
Grant/Award
65,829$13.7865,829(D)

View →

Mar 1, 2026Mar 3 9:18 PMDavid LebwohlEVP, Chief Medical Officer
Grant/Award
14,204$13.7814,204(D)

View →

Mar 1, 2026Mar 3 9:17 PMEdward J Dulac IIIEVP, Chief Financial Officer
Grant/Award
87,543$13.7887,543(D)

View →

Mar 1, 2026Mar 3 9:17 PMBirgit C SchultesEVP, Chief Scientific Officer
Grant/Award
56,000$13.7856,000(D)

View →

Mar 1, 2026Mar 3 9:16 PMEliana ClarkEVP, Chief Technical Officer
Grant/Award
10,505$13.7810,505(D)

View →